Article ; Online: Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment.
Acta paediatrica (Oslo, Norway : 1992)
2009 Volume 98, Issue 12, Page(s) 1882–1889
Abstract: Aim: To identify risk factors for a child with Henoch-Schönlein purpura (HSP) either to develop nephritis (HSPN) or to contract progressive course and to obtain the currently available evidence on the efficacy of treatment options in both preventing and ...
Abstract | Aim: To identify risk factors for a child with Henoch-Schönlein purpura (HSP) either to develop nephritis (HSPN) or to contract progressive course and to obtain the currently available evidence on the efficacy of treatment options in both preventing and treating the established renal disease. Method: Review of the literature published over the last two decades. Results: Persistent or recurrent purpura, severe abdominal symptoms and an older age proved as the most significant risk factors for later HSPN. The risks of long-term renal impairment are the highest in children having at presentation nephritic/nephrotic syndrome and/or more than 50% of glomeruli occupied by large crescents or sclerosing lesions. Randomized controlled trials (RCT) do not support short course prednisone at presentation of HSP in preventing persistent renal disease. Many uncontrolled studies using various treatment regimens have reported outcomes considered better than expected. However, the data from RCTs are sparse and no treatment options for the established renal disease can be currently recommended based on RCTs. Conclusion: Severity and/or duration of extrarenal HSP symptoms and an older age are the most significant risk factors for developing HSPN, whereas clinical and histological severity at HSPN onset are in general predictive of a long-term renal impairment. The existing evidence does not support of short course prednisone in preventing persistent renal disease. A well-designed RCTs are needed in children with moderately severe or rapidly progressive (crescentic) HSPN. |
---|---|
MeSH term(s) | Child ; Humans ; Nephritis/etiology ; Nephritis/prevention & control ; Nephritis/therapy ; Purpura, Schoenlein-Henoch/complications ; Randomized Controlled Trials as Topic ; Risk Factors ; Treatment Outcome |
Language | English |
Publishing date | 2009-12 |
Publishing country | Norway |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 203487-6 |
ISSN | 1651-2227 ; 0365-1436 ; 0803-5253 |
ISSN (online) | 1651-2227 |
ISSN | 0365-1436 ; 0803-5253 |
DOI | 10.1111/j.1651-2227.2009.01445.x |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Um IV Zs.95: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.